Log In
Print
BCIQ
Print
Print this Print this
 

Fablyn, lasofoxifene (formerly Oporia)

Also known as: CP-336,156

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionSelective estrogen receptor modulator (SERM)
Molecular Target Estrogen receptor
Mechanism of ActionSelective estrogen receptor modulator (SERM)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationOsteoporosis
Indication DetailsPrevent osteoporosis; Prevent osteoporosis in postmenopausal women; Treat osteoporosis; Treat osteoporosis in postmenopausal women at increase risk of fracture
Regulatory Designation

Partner

Ethicor Pharma Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today